{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/generalized-anxiety-disorder/diagnosis/diagnosis/","result":{"pageContext":{"chapter":{"id":"ed05a1cb-3048-5b62-a242-791415e2e034","slug":"diagnosis","fullItemName":"Diagnosis","depth":2,"htmlHeader":"<!-- begin field 113d5042-794a-45e4-a6b5-433803370dce --><h2>When should I suspect generalized anxiety disorder?</h2><!-- end field 113d5042-794a-45e4-a6b5-433803370dce -->","summary":"","htmlStringContent":"<!-- begin item 25f28210-9168-4b7a-9606-8514bf10211c --><!-- begin field 62f54a90-5db6-404b-8c4b-6633df626c9a --><ul><li><strong>Suspect generalized anxiety disorder (GAD) in a person who reports chronic, excessive worry which is not related to particular circumstances, and symptoms of physiological arousal such as restlessness, insomnia, and muscle tension. </strong></li><li><strong>International diagnostic criteria can be used to aid the diagnosis: </strong><ul><li>The DSM-V diagnostic criteria for GAD include:<ul><li>At least 6 months of excessive, difficult to control worry about everyday issues, that is disproportionate to any inherent risk, and causes distress, or impairment.</li><li>The worry is not confined to features of another mental disorder, or as a result of substance abuse, or a general medical condition.</li><li>The person experiences at least 3 of the following symptoms most of the time: restlessness/nervousness, being easily fatigued, poor concentration, irritability, muscle tension, or sleep disturbance.</li></ul></li><li>The ICD-10 diagnostic criteria for GAD include:<ul><li>Anxiety which is generalized and persistent but not restricted to, or even strongly predominating in, any particular environmental circumstances.</li><li>Variable dominant symptoms including persistent nervousness, trembling, muscle tension, sweating, lightheadedness, palpitations, dizziness, and epigastric discomfort.</li><li>Expression of fears such as that the person or a relative will shortly become ill or have an accident.</li></ul></li></ul></li><li><strong>Note: while the DSM-V and ICD-10 criteria broadly overlap, they differ in terms of some details, including duration of symptoms. Clinical judgement should therefore be used to determine the overall likelihood of a diagnosis of GAD.</strong> </li><li><strong>Be aware that, in primary care, people with GAD often present solely with physical symptoms such as headaches, muscle tension, gastrointestinal symptoms, back pain, and insomnia, and may not readily report worry or psychological distress. </strong>GAD is therefore a potential diagnosis in people reporting such symptoms, and those attending frequently who:<ul><li>Have a chronic physical health problem.</li><li>Do not have a physical health problem but are seeking reassurance about somatic symptoms.</li></ul></li><li><strong>Be aware of (and inquire about) factors that increase the likelihood of a GAD diagnosis, including:</strong><ul><li>Female sex.</li><li>Family history of anxiety.</li><li>Current physical or emotional stress.</li><li>History of physical or emotional trauma.</li><li>History of other anxiety disorders such as panic disorder, social phobia, or specific phobias.</li><li>Chronic pain or physical illness (such as arthritis, cancer, coronary heart disease, cerebrovascular accident, or chronic obstructive airway disease).</li><li>History of substance abuse.</li><li>Repeated visits with the same physical symptoms which do not respond to treatment (for example insomnia, headache, or fatigue).</li></ul></li><li><strong>Ask about the use of:</strong><ul><li>Over-the-counter or prescribed medications that can cause anxiety as a side-effect, such as salbutamol, theophylline, beta-blockers, herbal medicines (including ma huang, St. John's wort, ginseng, guarana, belladonna), corticosteroids, and some antidepressants.</li><li>Alcohol or illicit substances that can cause anxiety acutely and in withdrawal. </li></ul></li><li><strong>Carry out a physical examination. This is usually normal in the absence of co-existing medical problems or substance abuse,</strong><strong> but people with GAD may exhibit:</strong><ul><li>Increased heart rate.</li><li>Shortness of breath.</li><li>Trembling.</li><li>An exaggerated startle response.</li></ul></li><li>Consider <a class=\"topic-reference internal-reference\" href=\"/topics/generalized-anxiety-disorder/diagnosis/diagnosis/#differential-diagnosis\">differential diagnoses</a>. </li><li>Consider using a validated assessment tool such as the GAD-2 or <a class=\"topic-reference internal-reference\" href=\"/topics/generalized-anxiety-disorder/diagnosis/diagnosis/#generalized-anxiety-disorder-questionnaire\">GAD-7</a> questionnaires to determine the severity of GAD.</li><li>Be aware that Generalized anxiety disorder is often co-morbid with major depression, panic disorder, phobic anxiety disorders, health anxiety, and obsessive-compulsive disorder (OCD). For more information, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/depression/\">Depression</a> and <a class=\"topic-reference external-reference\" href=\"/topics/obsessive-compulsive-disorder/\">Obsessive-compulsive disorder</a>.</li><li><strong>Note:</strong> If at presentation the person is showing signs of marked functional impairment, severe comorbid depression, and/or the <a class=\"topic-reference internal-reference\" href=\"/topics/generalized-anxiety-disorder/diagnosis/diagnosis/#generalized-anxiety-disorder-questionnaire\">GAD-7</a> questionnaire score has indicated that they have severe anxiety, use clinical judgement to determine whether to assess their <a class=\"topic-reference internal-reference\" href=\"/topics/generalized-anxiety-disorder/management/management/#risk-of-suicide\">risk of suicide</a>.<ul><li>For advice on management of a person at risk of suicide, see the section <a class=\"topic-reference internal-reference\" href=\"/topics/generalized-anxiety-disorder/management/management/#management\">How should I manage a person with generalized anxiety disorder (GAD)?</a></li></ul></li></ul><!-- end field 62f54a90-5db6-404b-8c4b-6633df626c9a --><!-- end item 25f28210-9168-4b7a-9606-8514bf10211c -->","topic":{"id":"a764014a-3ca0-5cd4-899a-93af1654f111","topicId":"135bad2d-5cd6-4df9-b7cf-450677581600","topicName":"Generalized anxiety disorder","slug":"generalized-anxiety-disorder","lastRevised":"Last revised in February 2021","chapters":[{"id":"d7012fbb-d31d-52bd-8499-a790966332f6","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"ed3d6d57-ce79-58cd-9db0-91ce375231d0","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"da5c6fdc-0857-531f-acff-dee7423b2434","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"6d8405f1-6ec4-51b4-bc67-ce1dc419f266","slug":"changes","fullItemName":"Changes"},{"id":"dec78b2e-8a69-5c4e-9649-18c59fdff0ff","slug":"update","fullItemName":"Update"}]},{"id":"22e0cf56-e3b6-5744-9fc6-844673300989","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"b1e50b04-250b-56d8-b08c-a5e9adc44ecb","slug":"goals","fullItemName":"Goals"},{"id":"62e69cfa-f1e2-54d6-bea8-71f618ecc0f6","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"b044e4ad-382a-5b80-aa6f-0a91d1340216","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"b3327928-a8a3-5312-a69d-3d1d69eca670","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"a17705aa-783b-5363-8976-4095f0991e87","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"90f89dcc-cd30-59a4-a72e-1b755aec96f0","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"4e9ebfa7-2592-5db9-aa36-cc7c2b32fb70","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"96d96d1d-9961-5dca-a6f4-3327704e9832","slug":"definition","fullItemName":"Definition"},{"id":"736e4407-30b1-5e9c-a715-ca54b10fb58a","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"9ca6a146-b065-5743-a95f-2c3ec5008efa","slug":"prevalence","fullItemName":"Prevalence"},{"id":"f4bc4fe6-8936-515a-b07f-8c5d46c63495","slug":"complications","fullItemName":"Complications"},{"id":"71703d6d-00c1-5c15-b2b8-a2c1efc837fb","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"8866064e-cc95-5d6d-aeb3-eda0b5463df2","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"ed05a1cb-3048-5b62-a242-791415e2e034","slug":"diagnosis","fullItemName":"Diagnosis"}]},{"id":"55866755-f806-55a8-86b7-8e4e99072d8d","fullItemName":"Management","slug":"management","subChapters":[{"id":"93c33dd9-6fcf-5051-9acd-2fd56cad3d31","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"01b59b3b-cb00-5864-a191-83ef3dd8f60b","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"380e5777-c6f3-595b-ac6c-088be521e448","slug":"escitalopram-paroxetine-sertraline","fullItemName":"Escitalopram, paroxetine, and sertraline"},{"id":"e3d86ad6-7dbe-55e6-a0c6-d220d4b12b36","slug":"duloxetine-venlafaxine-modified-release","fullItemName":"Duloxetine and venlafaxine modified-release"},{"id":"96f243eb-7691-57e6-b968-6eeb41bc896d","slug":"pregabalin","fullItemName":"Pregabalin"},{"id":"207b91a3-65a7-5bfa-a236-8e796e759e3e","slug":"diazepam","fullItemName":"Diazepam"}]},{"id":"5c9792a8-5756-5d84-84c2-8301657b8478","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"795e451d-3583-5146-ab5d-137780924ebc","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"c9dc003a-66b8-5907-95b0-90c4ce0ea1d5","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"5bcc68a1-3691-5684-8f30-113cd9b37910","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"7fd23b16-785c-5716-bc47-74a34f4360f5","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"c7cfd852-0440-5a24-a57e-2d0dba08a1f2","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"4c65ec3e-2f85-5406-949d-d124e96e2e26","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"0d942b94-767d-5df9-82b9-f744d7714cd4","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"8866064e-cc95-5d6d-aeb3-eda0b5463df2","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"99b2578e-92cb-56ca-9d73-dbea75d09c64","slug":"generalized-anxiety-disorder-questionnaire","fullItemName":"Generalized anxiety disorder questionnaire","depth":3,"htmlHeader":"<!-- begin field 00407543-c99a-4e3d-89b7-b4f8d6c04906 --><h3>Generalized anxiety disorder questionnaire (GAD-7)</h3><!-- end field 00407543-c99a-4e3d-89b7-b4f8d6c04906 -->","summary":null,"htmlStringContent":"<!-- begin item b9c87f7f-63e2-4cdf-942c-3019a65c9903 --><!-- begin field bd5d4bde-4ee9-4323-957f-bdfeca879a46 --><ul><li>The generalized anxiety disorder questionnaire (GAD-7) consists of 7 questions. The score is calculated by assigning scores of 0, 1, 2, and 3, to the response categories of 'not at all', 'several days', 'more than half the days' and 'nearly every day' adding up to a possible total of 21. Scores of 5, 10, and 15 are taken as cut-off points for mild, moderate, and severe anxiety respectively. The person should be asked 'over the last 2 weeks, how often have you been bothered by any of the following problems?':<ul><li>Feeling afraid, as if something awful might happen.</li><li>Becoming easily annoyed or irritable.</li><li>Being so restless that it is hard to sit still.</li><li>Trouble relaxing.</li><li>Worrying too much about different things.</li><li>Not being able to stop or control worrying.</li><li>Feeling nervous, anxious, or on edge.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/generalized-anxiety-disorder/references/\">National Collaborating Centre for Mental Health, 2011b</a>]</p><!-- end field bd5d4bde-4ee9-4323-957f-bdfeca879a46 --><!-- end item b9c87f7f-63e2-4cdf-942c-3019a65c9903 -->","subChapters":[]},{"id":"8ff7c6ec-71e3-5179-b14a-366ecaeca7f3","slug":"differential-diagnosis","fullItemName":"Differential diagnosis","depth":3,"htmlHeader":"<!-- begin field 7882e6a8-ff48-44d3-a418-a800010400d1 --><h3>What else could it be?</h3><!-- end field 7882e6a8-ff48-44d3-a418-a800010400d1 -->","summary":null,"htmlStringContent":"<!-- begin item 3ffad90b-6276-4940-b79a-a8000103fa0a --><!-- begin field 6bb7fb4f-9950-43e5-bf3e-a800010400d1 --><p><strong>The differential diagnoses of generalized anxiety disorder (GAD) include:</strong></p><ul><li><strong>Situational anxiety</strong> — suggested by controllable anxiety that is not generally associated with pathological symptoms and relates to a particular life event, such as an upcoming examination.</li><li><strong>Adjustment disorder</strong> — suggested by temporary anxiety that has occurred in response to a life stressor and persists for no longer than 6 months after the stressor ends.</li><li><strong>Depression</strong> — suggested by an inability to feel pleasure and feelings of hopelessness. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/depression/\">Depression</a>.</li><li><strong>Panic disorder </strong>— suggested by recurrent episodes of sudden onset anxiety, in the absence of multi-themed worry. During an acute attack, the person experiences at least 4 symptoms from the following: shortness of breath, palpitations, shakiness, nausea, hot or cold flushes, dizziness, and fear of dying. Also frequently accompanied by avoidance behaviours (of activities where escape would be difficult). Panic may exist alongside GAD.</li><li><strong>Social phobia</strong> — suggested by anxiety or persistent fear that is limited to social situations and fear of social scrutiny or embarrassment. Avoidance behaviour is commonly present.</li><li><strong>Obsessive-compulsive disorder</strong> — suggested by anxiety due to compulsions or obsessions. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/obsessive-compulsive-disorder/\">Obsessive-compulsive disorder</a>.</li><li><strong>Post-traumatic stress disorder</strong> — suggested by anxiety that is caused by exposure to reminders of past trauma. The person may report feeling as if they are reliving these events through flashbacks, nightmares etc. For more information, see the CKS topic on  <a class=\"topic-reference external-reference\" href=\"/topics/post-traumatic-stress-disorder/\">Post-traumatic stress disorder</a>.</li><li><strong>Somatoform disorders</strong> — suggested by anxiety related to specific physical complaints, which have no medical basis.</li><li><strong>Anorexia nervosa </strong>— suggested by anxiety related to fear of gaining weight. Bodyweight is usually < 85% of ideal. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/eating-disorders/\">Eating disorders</a>.</li><li><strong>Substance and alcohol misuse/withdrawal </strong>is frequently associated with anxiety, especially among men. Consider a urine drug screen if substance misuse requires confirmation.  For more information on alcohol misuse, see the CKS topic on<a class=\"topic-reference external-reference\" href=\"/topics/alcohol-problem-drinking/\">Alcohol - problem drinking</a>.</li><li><strong>Medication-induced anxiety</strong> — suggested by anxiety triggered by exposure to medications including salbutamol, theophylline, corticosteroids, antidepressants, and some herbal medicines. Caffeine may also be a trigger. Withdrawal from CNS depressants can also trigger anxiety.</li><li><strong>Cardiac disease</strong> — suggested by symptoms such as palpitations, sensation of rapid or skipped heartbeat, dizziness, dyspnoea and chest pain on exertion, and numbness. Examination may reveal hypertension, hypotension, tachycardia or bradycardia, or S3 or S4 gallops. Investigations such as angiogram, echocardiogram, exercise stress test, and/or ECG should be arranged to confirm the diagnosis. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/heart-failure-chronic/\">Heart failure - chronic</a> and <a class=\"topic-reference external-reference\" href=\"/topics/mi-secondary-prevention/\">MI - secondary prevention</a>.</li><li><strong>Pulmonary disease</strong> — suggested by a history of lung conditions such as asthma or COPD, the person being a current or previous smoker, and signs/symptoms such as wheezing, cough, respiratory distress, or sputum production, and a feeling of suffocation. Pulse oximetry may reveal low oxygen saturation. Pulmonary function tests should be arranged to confirm the diagnosis. For more information, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/asthma/\">Asthma</a> and <a class=\"topic-reference external-reference\" href=\"/topics/chronic-obstructive-pulmonary-disease/\">Chronic obstructive pulmonary disease</a>.</li><li><strong>Hyperthyroidism</strong> — suggested by weight loss, warm moist skin, heat intolerance, ophthalmopathy, or goitre. Thyroid function tests should be arranged to confirm the diagnosis. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/hyperthyroidism/\">Hyperthyroidism</a>.</li><li><strong>Anaemia</strong> — suggested by fatigue, dyspnoea, and palpitations. For more information, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/anaemia-iron-deficiency/\">Anaemia - iron deficiency</a> and <a class=\"topic-reference external-reference\" href=\"/topics/anaemia-b12-folate-deficiency/\">Anaemia - B12 and folate deficiency</a>.</li><li><strong>Infection</strong> — suggested by anxiety and additional symptoms of fever, night sweats, or cough, which resolve following successful treatment.</li><li><strong>Irritable bowel syndrome</strong> — suggested by alteration of bowel habit associated with pain, and abdominal discomfort, bloating, or distention. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/irritable-bowel-syndrome/\">Irritable bowel syndrome</a>.</li><li><strong>Phaeochromocytoma</strong> — suggested by anxiety that co-exists with hypertension and/or tachycardia. 24-hour urine for vanillylmandelic and metanephrines should be arranged to confirm the diagnosis.</li></ul><!-- end field 6bb7fb4f-9950-43e5-bf3e-a800010400d1 --><!-- end item 3ffad90b-6276-4940-b79a-a8000103fa0a -->","subChapters":[]},{"id":"018dd989-896d-5686-808d-03e48319c2cb","slug":"basis-for-recommendation-aae","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field 5dc8da09-b14c-4049-aa91-d6dfa86110d7 --><h3>Basis for recommendation</h3><!-- end field 5dc8da09-b14c-4049-aa91-d6dfa86110d7 -->","summary":null,"htmlStringContent":"<!-- begin item aaeda44a-a64a-4d6c-9347-426b2c14b0ea --><!-- begin field d76f84c3-e5de-456f-8f87-5d0880dc25cc --><p>The recommendations on diagnosing generalized anxiety disorder (GAD) are based on expert opinion in the BMJ Best Practice guideline <em>Generalised anxiety disorder</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/generalized-anxiety-disorder/references/\">BMJ Best Practice, 2017</a>], the British Association for Psychopharmacology guideline <em>Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/generalized-anxiety-disorder/references/\">Baldwin et al, 2014</a>], the<em> </em>National Institute for Health and Care Excellence (NICE) guidelines <em>Generalized anxiety disorder and panic disorder in adults: Management  </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/generalized-anxiety-disorder/references/\">NICE, 2011</a>], and <em>Common mental health disorders: Recognition and pathways to care</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/generalized-anxiety-disorder/references/\">National Collaborating Centre for Mental Health, 2011b</a>], and narrative review articles on <em>Generalized anxiety disorder: diagnosis and treatment </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/generalized-anxiety-disorder/references/\">Hoge and Fricchione, 2012</a>], <em>Anxiety</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/generalized-anxiety-disorder/references/\">Craske and Stein, 2016</a>], and <em>Generalized anxiety disorder</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/generalized-anxiety-disorder/references/\">Stein and Sareen, 2015</a>].</p><h4>Use of generalized anxiety disorder (GAD) questionnaires</h4><ul><li>NICE recommends the use of the GAD-2 or GAD-7 as part of the assessment for GAD.<ul><li>The GAD-2 is a shortened version of GAD-7 consisting of the first two questions. An example of the GAD-7 questionnaire can be found within the NICE guideline on<em> Common mental health disorders: Recognition and pathways to care</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/generalized-anxiety-disorder/references/\">National Collaborating Centre for Mental Health, 2011b</a>].</li><li>A 2016 meta-analysis pooled data from a total of 11 studies and found that at a cut-off score of 8, GAD-7 had pooled sensitivity values of 0.83 (95% CI 0.71 to 0.91) and pooled specificity values of 0.84 (95% CI 0.70 to 0.92). Cut-off scores of 7-10 also had similar pooled estimates of sensitivity/specificity.</li><li>Pooled data from 6 studies showed that at a cut-off point of 3, GAD-2 had pooled sensitivity values of 0.76 (95% CI 0.55 to 0.89) and pooled specificity values of 0.81 (95% CI 0.60 to 0.92).</li><li>The authors concluded that the GAD-7 had acceptable properties for identifying GAD at cut-off scores 7-10, and that the GAD-2 had acceptable properties for identifying GAD at a cut-off score of 3, but that further validation studies are needed [<a class=\"bibliography-reference internal-reference\" href=\"/topics/generalized-anxiety-disorder/references/\">Plummer et al, 2016</a>].</li></ul></li></ul><h4>Risk of suicide</h4><ul><li>The advice to consider assessing risk of suicide in people who at presentation show signs of marked functional impairment, severe comorbid depression, and/or their GAD-7 questionnaire score has indicated severe anxiety, is pragmatic, based on what CKS considers to be good clinical practice.</li></ul><!-- end field d76f84c3-e5de-456f-8f87-5d0880dc25cc --><!-- end item aaeda44a-a64a-4d6c-9347-426b2c14b0ea -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}